Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Grégory Behar
CEO | Chief Executive Officer | 55 | 01/01 |
Director of Finance/CFO | - | 03/04/23 | |
Ulrike Lemke
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/21 |
Luc Burgard
COO | Chief Operating Officer | 43 | - |
Marc Funk
BRD | Director/Board Member | 64 | 01/01/21 |
Human Resources Officer | - | - | |
Kieran Chouhan
PRN | Corporate Officer/Principal | - | 01/02/19 |
Bernard Pluta
PRN | Corporate Officer/Principal | - | 01/10/15 |
Shabbir Mostafa
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | 60 | 01/06/15 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Steven Klosk
BRD | Director/Board Member | 67 | 01/03/21 |
Director/Board Member | 67 | 01/01/21 | |
Richard Ridinger
CHM | Chairman | 66 | 01/03/21 |
Marc Funk
BRD | Director/Board Member | 64 | 01/01/21 |
Director/Board Member | 43 | 01/03/21 | |
Henrik Giver
BRD | Director/Board Member | 35 | 01/01/21 |
Director/Board Member | - | - |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 370 000 | 0 | 0 | 56,25 % |
Action B | 10 | 21 312 000 | 0 | 0 | |
Action C | 1 | 79 803 683 | 57 089 305 ( 71,54 %) | 0 |
Coordonnées société
Sociétés du groupe
Nom | Catégorie et Secteur |
---|---|
Recipharm Ltd.
Recipharm Ltd. Pharmaceuticals: MajorHealth Technology Recipharm Ltd. manufactures pharmaceutical products. It offers branded and generic products. The company was founded on August 10, 2012 and is headquartered in Ashton-under-Lyne, the United Kingdom. |
Pharmaceuticals: Major
|
Recipharm Holdings Ltd.
Recipharm Holdings Ltd. MiscellaneousMiscellaneous Recipharm Holdings Ltd. operates from a multipurpose manufacturing facility, The company was founded on August 10, 2012 and is headquartered in Ashton-Under-Lyne, the United Kingdom. |
Miscellaneous
|
Recipharm Venture Fund AB
Recipharm Venture Fund AB Investment ManagersFinance Recipharm Venture Fund AB is a venture capital fund that makes strategic investments in start-ups and biotechnology companies that are seen as important to Recipharm's business. The fund invests in both private and public companies. |
Investment Managers
|
Secteur
Varia. 1 janv. | Capi. | |
---|---|---|
+5,31 % | 69,91 Md | |
+10,97 % | 9,03 Md | |
-16,83 % | 4,75 Md | |
+43,48 % | 4,31 Md | |
+3,20 % | 3,88 Md | |
+18,82 % | 2,37 Md | |
-21,36 % | 2,26 Md | |
-29,67 % | 2,2 Md | |
+8,38 % | 1,98 Md |